Form 4: Pulmonx Director Glendon E. French III Sells 20,000 Shares
SEC Form 4 Filing
Director Glendon E. French III of Pulmonx Corp sold 20,000 shares of common stock on October 17, 2024, at a weighted average price of $6.52.
Summary
- On October 17, 2024, Glendon E. French III, a director of Pulmonx Corp, sold 20,000 shares of common stock.
- The sale was executed at a weighted average price of $6.52 per share.
- The transactions were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on June 10, 2024.
- Following the transaction, French directly owns 1,091,974 shares of Pulmonx Corp.
- The price range for the shares sold was between $6.50 and $6.73.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction was pre-planned under a 10b5-1 trading plan and doesn't necessarily reflect the director's current outlook on the company.
Industry Context
Sales by company insiders are a common occurrence and are closely watched by investors for signals about the company's prospects; however, sales under 10b5-1 plans are less likely to be indicative of the insider's view of the company's prospects.
Stakeholder Impact
- The sale of shares by a director could create short-term uncertainty among shareholders.
Key Dates
| Date | Description |
|---|---|
| June 10, 2024 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| October 17, 2024 | Date of the stock sale transaction |
| October 21, 2024 | Date of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.